KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS

Cited by (207)

Items 201–207 of 207

1. Changes in depression symptom network structure following ketamine treatment in treatment-resistant depression
   Joshua E. Curtiss, Laya Dasari, Julianne Origlio, Catherine Schuessler, Lauren B. Fisher, Michael D. Kritzer, Minna Behnan, Ava Licht, Nicholas Huempfner, Eric Andrews et al. · 2026 · Journal of Affective Disorders
2. Beyond the High: A Narrative Review of the Chronic Complications of Recreational Ketamine Use
   Karen L Erskine, Paul Ivor Dargan, David Michael Wood · 2026 · British Journal of Hospital Medicine
3. Effect of intraoperative ketamine on pain, opioid use, and psychological recovery in orthopedic trauma patients (KOPM trial): protocol for a randomized, single-blind trial
   Camas Curran, Evan J. Hernandez, Jennifer Hudnall, Jaspinder Sra, Max E. Davis · 2026 · Pain Management
4. Sustained pharmacodynamic effects of S‐ketamine on cortical excitability and resting‐state brain activity: A randomized, placebo‐controlled trial
   Catherine M.K.E. de Cuba, Annika A. de Goede, Joost van Mechelen, Laura G. J. M. Borghans, Lazarenko Aa, Erik Olofsen, Maria Joanna Juachon, Robert Jan Doll, Amy Gillespie, Catherine J. Harmer et al. · 2026 · British Journal of Clinical Pharmacology
5. An integrative model of ketamine-induced memory dysfunction: From synapse to circuit in clinical context
   Mola Mohammadi, Amin Saeedi, Ali Asghar Kheirkhah Vakilabad, Fatemeh Seyedi, Ahmad Golkar, Yousef Baghcheghi · 2026 · NeuroToxicology
6. The Pyrazolone Scaffold: A Privileged Motif for Molecular Hybridization in Drug Discovery
   Ke Tang, Yao Liu, Jingning Luo, Shiqin Cong · 2026 · ChemMedChem
7. BindingDB Entry 50001728: BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder.
   BindingDB · 2020 · UC San Diego